baber/WOPTO huggingface dataset:
Patent JP-S6351689-B2 (JP)
IPC: A61B1/12
Filed: 1981-01-14
Abstract: An endoscope comprising an insertion section [3] having a foremost end portion inserted into a body cavity, and connected to an operating section [1], the insertion section housing a suction path [4] of which one end is opened at the foremost end thereof and of which the other end projects into the operating section, and a suction changeover mechanism [5] arranged at the operating section. The suction changeover mechanism [5] includes a cylinder [6] having a connecting opening [6b] connected to the suction source [P], a pressure discharge opening [6a] to the outside atmosphere and a further opening [4a] connected to the other end of the suction path, and a valve [10] having a body [10a] fitted into the cylinder an a through-hole formed in the body for normal communication of the pressure discharge opening [Ga] with the connecting opening [6b]. The body resiliently shuts off the communication between the further opening [4a], the discharge opening [6a] and the connecting opening [6b] when the pressure discharge opening [6a] communicates with the outside atmosphere but is resiliently deformed due to negative pressure caused by the suction source in the cylinder to communicate the further opening [4a] with the suction path when the pressure discharge opening is shut off from the outside atmosphere.
Patent JP-S6331455-B2 (JP)
IPC: A61K31/535
Filed: 1979-01-20
Abstract: Substituted morpholine derivatives, such as, for instance, the compound 2-[ alpha -(2-methoxy-phenoxy)-benzyl]-morpholine are disclosed. The claimed compounds are active on the central nervous system, and may be used as antidepressant agents.
Patent JP-2991985-B2 (JP)
IPC: A61K31/425
Filed: 1997-01-16
Granted: 1999-12-20
Abstract: Compounds of formula (I) : <CHEM> (in which: R<0> is hydrogen, methyl or hydroxymethyl; R<1> is substituted alkyl; R<2> and R<3> are each hydrogen, halogen, hydroxy, alkoxy, carboxy, alkoxycarbonyl, alkyl, nitro, haloalkyl, or substituted alkyl; X is oxygen atom or a sulphur; and Ar optionally substituted phenyl or naphthyl); and pharmaceutically acceptable salts thereof have a variety of valuable pharmaceutical activities, including anti-diabetic and anti-obesity activities; in addition, they are capable of treating or preventing hyperlipemia and hyperglycemia and, by inhibiting the action of aldose reductase, they can also be effective in the treatment and prevention of complications of diabetes.
Patent JP-H0784465-B2 (JP)
IPC: C07D409/02
Filed: 1987-01-16
Abstract: The invention relates to new nitrogen-arylmethoxy-thiophene derivatives of the formula I    <IMAGE>  I  wherein the R-CH2-O-group is in position 4 or 5 of the thiophene ring, R denotes a 2-pyridinyl- or 2-quinolinyl group and R1 denotes a -COO-lower alkyl-, -CO-(CH2)n-CH3 or -CH(OH)-(CH2)n-CH3 group, wherein n represents an integer from 2 to 6, and their hydrates and/or their pharmaceutically acceptable acid addition salts, a process for their preparation and pharmaceutical products containing these compounds. The new compounds and their salts have useful pharmacological properties. They can be used as active compounds for medicaments for the treatment and prevention of diseases, caused by a disturbance in arachidonic acid metabolism.
Patent AU-662311-B2 (AU)
Title: Recombinant antibodies specific for a growth factor receptor
Inventor: WELS WINFRIED STEPHAN
IPC: A61K47/48
Filed: 1992-01-23
Granted: 1995-08-31
Abstract: The invention concerns recombinant antibodies directed to the extracellular domain of the human growth factor receptor c-erbB-2 comprising a light chain variable domain and a heavy chain variable domain of a monoclonal antibody, monoclonal antibodies directed to c-erbB-2 themselves, a method of manufacture of said recombinant antibodies and said monoclonal antibodies, hybridoma cells secreting said monoclonal antibodies, a method of manufacture of said hybridoma cells, DNA coding for the heavy chain variable domain, for the light chain variable domain and for the recombinant antibody, a method of manufacture of said DNA, hybrid vectors suitable for expression of said DNA, host cells transformed with said DNA, and the use of said recombinant antibodies and said monoclonal antibodies in the diagnosis and treatment of tumors.
Patent AU-557153-B2 (AU)
Title: Filling device
Inventor: PERIGO JOHN ALFRED
IPC: F16L37/28
Filed: 1983-01-28
Granted: 1986-12-11
Abstract: A separable coupling for transferring a liquid or semi-liquid food product to or from a container (14) comprises a closure (10) on the container, and a coupling member (12) attached to a supply or discharge conduit (62) and which is releasably connectable with the closure. Valves (25,46) on the closure and coupling member are connected in series in the product flow path when the coupling is made. They are connected mechanically together and actuated in series so that the valve (46) of the coupling member is actuated through the agency of the valve (25) on the closure in a fail-safe manner. Provision is made for feeding superheated steam to the region of the product flow path lying between the valves, so that the exposed surfaces of the closure and coupling member can be sterilised or purged before and after a filling or discharging operation.
Patent AU-594295-B2 (AU)
Title: Selfsupporting-corona-discharge-electrode
Inventor: LELUSCHKO GEORG
IPC: B03C3/41
Filed: 1988-04-14
Granted: 1990-03-01
Abstract: Selfsupporting mastlike corona discharge electrodes are proposed for use in a dustcollecting electrostatic precipitator having gas passage-forming platelike collecting electrodes. From a metal strip which has the same width everywhere the corona discharge electrode can be manufactured continuously in any desired length and virtually without a waste of material. By cutting and bending operations the metal strip is formed to constitute a selfsupporting corona discharge electrode which has an adequate flexural stiffness and is provided with the required corona discharge tips.
Patent AU-548623-B2 (AU)
Title: Production of antibodies
Inventor: LINGGOOD MARGARET ANNELI
IPC: A23C9/20
Filed: 1983-08-30
Granted: 1985-12-19
Abstract: Antibodies are produced by hyperimmunising a mammal, such as a cow, with a vaccine derived from E. coli bacteria. The bacterial strains in the vaccine are selected on the basis of their virulence characteristics, especially adhesion factors (pili), associated with gastroenteric disease in humans. The antibodies can be recovered from the mammal's milk or serum, and used in human foods.
Patent AU-565302-B2 (AU)
Title: Integrated distribution system
Inventor: BOTTLE DIETRICH
IPC: H04Q11/04
Filed: 1983-09-09
Granted: 1987-09-10
Abstract: 1. Integrated communication system containing a narrowband communication network with narrowband switching facilities (1), a broadband switching network with broadband switching facilities (17), and digital broadband distribution switching networks with broadband distribution facilities (14), the broadband switching and distribution facilities being controlled fron the narrowband switching facilities, characterized in that in the case of a narrowband switching facility which has a digital switching network (1) and terminal modules (2, 4) connected therewith and wherein the control facilities are spatially distributed to the terminal modules (2, 4), there is provided an additional terminal module (16) which is connected to the digital switching network (1), contains the control facilities for one of the broadband switching facilities (17), and is connected via the digital switching network (1) to the narrowband communication network for the exchange of the signalling and control information necessary to handle the calls in the broadband switching network.
Patent AU-651494-B2 (AU)
Title: Rock drilling device
Inventor: RODERT JORGEN
IPC: E21B7/20
Filed: 1992-09-23
Granted: 1994-07-21
Abstract: Rock drilling device comprising a drilling tool with a set of tubes (7) and a set of rods (9) arranged therein. The drilling tool comprises a number of sections which each comprises a tube (7), a rod (9) and an end piece (11). The rod is provided with projections (10) at least near one of its ends for cooperation with parts (13,14) with reduced diameter in the tube and end piece respectively. The part (13) in the tube limits the movement of the rod in a direction away from the end piece. The part (14) in the end piece limits the movement of the rod in a direction towards the end piece. All thread connections (12) between different sections of the drilling tool and between tube and end piece within each section are made in the same way and thus equally easy to break. <IMAGE>
Patent AU-721526-B2 (AU)
Title: Conversion of a PCM signal into a UPWM signal
Inventor: RISBO LARS
IPC: H03M1/82
Filed: 1997-03-26
Granted: 2000-07-06
Abstract: To correct non-linearity and noise in the conversion of a pulse code modulated signal (PCM) into a uniform pulse width modulated signal (UPWM), a model is made of the known non-linearity in the conversion by dividing a plurality of non-linearity components in the model, where the polynomial components are separately weighed with filter coefficients. The model is used as a basis for the construction of a filter of the Hammerstein type whose non-linear parts consist of a division of the PCM signal into a plurality of powers, and whose linear parts are approximated by means of the model made. With the circuit of the invention it is now possible to construct a purely digital amplifier which has a great efficiency, low weight, etc.
Patent AU-693906-B2 (AU)
Title: Acetabular bone graft impactor
Inventor: ASHBY ALAN
IPC: A61F2/46
Filed: 1995-08-10
Granted: 1998-07-09
Abstract: An acetabular bone graft impactor comprising a contact surface at least part of which is located on a head connected to a shaft provided with an anvil, and means for altering the shape of the contact surface. <MATH>
Patent AU-698837-B2 (AU)
Title: Container and closure having an outer foil cover
Inventor: GILES GEOFFREY ALAN
IPC: B65D41/62
Filed: 1995-06-19
Granted: 1998-11-12
Abstract: A container, suitable for pourable fluids such as beverages, has a closure 16 which is rotated relative to the container for opening and an outer foil cover 19, the foil cover extending beyond the edge of the closure to lie against the container wall and the closure having one or more projections 20 that puncture or weaken the foil cover on rotation of the closure. The projections preferably provide a serrated edge of castellated shape (figure 4). The closure may fit directly on the container neck or on an adapter 14 fastened on the neck. The closure may engage the neck/adapter by screw threads or by way of cooperating cam surfaces. <IMAGE>
Patent AU-662366-B2 (AU)
Title: Improvements relating to a heater unit for a self-heating container
Inventor: TAN PHANG KWANG
IPC: A47J36/30
Filed: 1992-11-06
Granted: 1995-08-31
Abstract: PCT No. PCT/GB92/02056 Sec. 371 Date Dec. 6, 1993 Sec. 102(e) Date Dec. 6, 1993 PCT Filed Nov. 6, 1992 PCT Pub. No. WO93/08723 PCT Pub. Date May 13, 1993.The invention is a heater unit for installation in a disposable self-heating container having a solid fuel tablet, a slidably activated friction-responsive igniter, and a single piece carrier member produced by folding sheet material where the carrier member includes one or more fingers for securing the solid fuel tablet to the carrier member, a sleeve for operatively securing the igniter to the carrier member to enable the igniter to ignite the solid fuel tablet, and tabs securable to the container to facilitate installation of the heater unit therewith.
Patent AU-739523-B2 (AU)
Title: Method for preferential outer retinal stimulation
Inventor: GREENBERG ROBERT J
IPC: A61N1/36
Filed: 1999-03-11
Granted: 2001-10-18
Abstract: A method of focused phosphene generation through deeper intermediate retinal cellular electrical stimulation to the exclusion of direct ganglion cellular electrical stimulation comprises the steps of: a) positioning a stimulating electrode in the vicinity of retinal tissue; and b) applying a long duration stimulation signal to the electrode such that deeper intermediate retinal cells are preferentially stimulated over the retinal ganglion cells and proximal overlying surface axons. The long duration stimulation signal is preferably a biphasic signal having a negative and a positive phase pulse which is applied in cathodic fashion. To preferentially stimulate the deeper intermediate retinal elements the duration of the long duration stimulation signal is greater than 0.5 millisecond per phase pulse, and preferably equal to or longer than 2 millisecond per phase pulse. The biphasic signal is preferably adjusted to simulate a monophasic signal by adjusting the magnitude of the negative pulse in relation to positive pulse, and by adjusting the duration of the positive pulse in relation to the negative pulse to maintain approximately net zero charge introduction. Preferably, the ratio of the negative pulse to the positive pulse is approximately 10:1 or greater.
Patent AU-726209-B2 (AU)
Title: Feeding container
Inventor: TEGLBJARG CASPAR
IPC: A61J9/00
Filed: 1997-05-14
Granted: 2000-11-02
Abstract: PCT No. PCT/SE97/00787 Sec. 371 Date Dec. 2, 1998 Sec. 102(e) Date Dec. 2, 1998 PCT Filed May 14, 1997 PCT Pub. No. WO97/47269 PCT Pub. Date Dec. 18, 1997A feeding bottle for infants useful for travelling and including a storage compartment for the nipple and a heater. The bottle includes an outer wall with an opening for the nipple at a first end and which turns inwardly at the opposite end defining a second opening, the wall terminating to form a closed portion within the bottle. The bottle thus includes a first storage space for the feeding material and a second storage space for the heater and for a nipple.
Patent AU-575362-B2 (AU)
Title: Method of detecting immiune complexes in serium
Inventor: RECKEL RUDOLPH P
IPC: C07K16/00
Filed: 1984-11-06
Granted: 1988-07-28
Abstract: Method and test kit for detecting Clq-containing complexes in human serum containing native serum Cl. The method uses a monoclonal antibody which selectively reacts with human Clq in the presence of native human serum Cl. Preparation of hybridomas generating such antibodies is also disclosed. The method is applicable to detection of autoimmune diseases and AIDS.
Patent AU-683013-B2 (AU)
Title: Environmentally safe underground piping system
Inventor: WEBB MICHAEL C
IPC: F17D5/02
Filed: 1993-02-18
Granted: 1997-10-30
Abstract: A secondarily contained underground piping system which interconnects at least one underground storage tank dispensing pump to at least one above-ground dispensing unit. The system includes an originating chamber surrounding the dispensing pump and having at least one opening therein for pipe access thereto. A terminating chamber is positioned directly under the above-ground dispensing unit and includes at least one opening therein for pipe access thereto. A transfer pipe is operably connected from the dispensing pump to the above-ground dispensing unit, and passes through the openings in the originating chamber and the opening in the terminating chamber. Seals are provided for sealing the passage of the transfer pipe through the openings. The transfer pipe includes an inner primary supply pipe for transferring fuel and an outer secondary containment pipe for defining an interstitial space between the primary pipe and the containment pipe.
Patent AU-677775-B2 (AU)
Title: A grand piano having a lower lid
Inventor: REVENAUGH DANIELL
IPC: G10C3/02
Filed: 1993-02-26
Granted: 1997-05-08
Abstract: A grand piano having a lower lid attached thereto by hinges, and a lid designed for attachment to the bottom of a grand piano. The lid completely covers the bottom of the piano case when latched in a closed position. In its closed position, the lower lid protects the soundboard from damage (such as during transportation of the piano) and mutes the piano's sound. The lower lid of the invention is designed so that, when released from its closed position and pivoted downward into an open position, it will reflect sound from the soundboard outward from the front of the piano. Preferably, the angular orientation of the lower lid in its open position is chosen to reinforce and focus the projection of sound within a desired frequency range (for example, midrange sounds) to a desired target region. Such optimal angular orientation can be determined experimentally. In one embodiment, the lower lid consists of two or more panels connected together by hinges, so that it can be detached from the piano and folded into a compact volume for convenient handling and storage. The dimensions of the lid and the positions of hinges which connect its panels are preferably predetermined so that lid has an optimal orientation for reinforcing projection of midrange sounds (or sounds within another desired frequency range) in a typically-sized room or concert hall when the lid is lowered to an open position in which it rests on the floor.
Patent AU-658319-B2 (AU)
Title: Apparatus and method for linking an elongated extruded meat product
Inventor: TOWNSEND RAY T
IPC: A22C11/10
Filed: 1993-08-04
Granted: 1995-04-06
Abstract: Three parallel auger shafts (44) having identical flighting (46) thereon disposed on axes equally spaced from each other to provide a central axis (52) equidistant from the axes of the augers. An elongated strand (54) of extruded meat product is moved through the central axis thereof so that when the flighting on the augers meet at a common point, the diameter of the strand is compressed to create a link (56) in the strand. A second embodiment of the invention places the three augers (44) in a rotatable assembly with the augers (44) rotating about their own axes as well as the central axis. A third embodiment utilizes a casing control element (78) on the inlet end of each auger (44) to cooperate with the nozzle or horn (16) through which the extruded material is being delivered whereupon the control elements (78) rotate the casing material and control the expansion of the casing material to its full diameter as the meat emulsion flows into the casing. <IMAGE>
Patent AU-701476-B2 (AU)
Title: Methods and compositions for secretion of heterologous polypeptides
Inventor: SIMMONS LAURA C
IPC: C12N15/70
Filed: 1996-02-27
Granted: 1999-01-28
Abstract: The instant invention discloses the unexpected result that mutant signal sequences with reduced translational strength provided essentially complete processing and high levels of expression of a polypeptide of interest as compared to wild type signal sequences, and that many mammalian polypeptides require a narrow range of translation levels to achieve maximum secretion. A set of signal sequence vectors provides a range of translational strengths for optimizing expression of a polypeptide of interest.
Patent AU-770531-B2 (AU)
Title: Intraurethral magnetic valve
Inventor: DAVIS PHILLIP J
IPC: A61F2/00
Filed: 1999-07-09
Granted: 2004-02-26
Abstract: An intraurethral magnetic valve for insertion in the human urethra of a person suffering from incontinence. The intraurethral magnetic valve includes a nonferromagnetic cylindrical housing, a valve seat assembly attached to one end of the housing, a spherical magnetic valve element disposed for universal movement in the housing, and a ring for retaining the valve element which is attached at the other end of the housing. The valve seat assembly has a nonferromagnetic valve seat sealing surface and ferromagnetic ring, each having concentric apertures for passage of fluid. The valve element is maintained in closed check position against the valve seat by attraction to the ferromagnetic ring, restricting the flow of fluid through the valve. An external magnet is used to impart magnetic torque and attraction to the valve element displacing it from the valve seat and opening the valve for fluid flow. On removal of the external magnet, the valve element returns to its closed check position on the valve seat. The intraurethral magnetic valve may further include a mechanism for relieving excessive fluid pressure at the end of the housing having the valve seat assembly, in which the valve seat assembly is axially slidable within the housing, rather than being attached to the housing. The mechanism has a spring disposed in the housing on the side of the valve seat assembly opposite the valve element, between another retaining ring and the valve seat assembly. The spring pushes the valve seat assembly against an annular flange attached to the housing. Under normal conditions, the valve seat assembly engages the annular flange. During excessive hydrostatic pressure, the pressure against the valve element and valve seat assembly compresses the spring to disengage the seat assembly from the annular flange and permit slow release of fluid through a passageway around the valve seat assembly until the excessive pressure is reduced.
Patent AU-726515-B2 (AU)
Title: Novel unit dose of budesonide
Inventor: NILSSON HANS
IPC: A61P37/00
Filed: 1997-11-28
Granted: 2000-11-09
Abstract: A new metered unit dose comprising 40 mug or less of budesonide is disclosed as well as a formulation thereof and the use thereof for the treatment of conditions in the nose.
Patent AU-671896-B2 (AU)
Title: Automotive refinish primer surfacer containing acetoacetate functional polyesterpolyol, a polyacrylate, and an amine functional epoxy resin
Inventor: WALTERS DAVID NEIL
IPC: C08G59/14
Filed: 1993-12-15
Granted: 1996-09-12
Abstract: Curable coating compositions are provided containing an amine group containing polyepoxide resin, an acetoacetate containing polyester having a weight average molecular weight of at least 1000, and a polyacrylate containing material. The amine group containing polyepoxide can be modified with a ketone and/or an aldehyde to form a ketimine and/or an aldimine containing polyepoxide. The compositions are useful as coatings, particularly as ambient or low temperature curable automotive refinish primer coatings having good corrosion resistance, adhesion to both substrate and other organic coatings, sandability and pot-life.
Patent AU-535181-B2 (AU)
Title: Alpha-azolyl gylcol derivatives
Inventor: ZEEH BERND
IPC: C07D249/08
Filed: 1980-06-27
Granted: 1984-03-08
Abstract: alpha -Azolyl-glycol derivatives of the formula    <IMAGE>  I  where R1 is alkyl, R2 is alkyl or unsubstituted or substituted phenyl, R3 is hydrogen, alkyl, alkenyl, alkynyl or unsubstituted or substituted benzyl, R4 is unsubstituted or substituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, arylalkyl or heteroarylalkyl or, where n=1, may also be unsubstituted or substituted aryl or heteroaryl, X is CH or N and n is O or 1, their salts and metal complexes tolerated by crop plants, their preparation, and agents containing these derivatives for controlling fungi and regulating plant growth.
Patent AU-720529-B2 (AU)
Title: Lantibiotic mutants and chimeras of enhanced stability and activity
Inventor: HANSEN J NORMAN
IPC: A61P31/00
Filed: 1996-09-30
Granted: 2000-06-01
Abstract: Nisin-subtilin mutant and chimeric prepeptides were constructed and expressed in a Bacillus subtilis strain that possesses all of the cellular machinery for making subtilin, except for the presubtilin gene. The chimera SL-Nis1-11-Sub12-32 was prepared. The prepeptide has the subtilin leader sequence (SL), the N-terminal portion of the structural region was derived from nisin, and the C-terminal portion of the structural region derived from subtilin. This chimera was accurately and efficiently converted to the mature lantibiotic, as demonstrated by a variety of physical and biological activity assays. In contrast, a (SL-Sub1-11-Nis12-34) chimera was processed into a heterogeneous mixture of products, none of which appeared to be the correct chimeric lantibiotic. The mixture did, however, contain an active minor component with a biological activity that exceeded nisin itself.